ABVX
Abivax SA American Depositary Shares
NASDAQ: ABVX · HEALTHCARE · BIOTECHNOLOGY
$106.24
-3.30% today
Updated 2026-04-29
Market cap
$8.42B
P/E ratio
—
P/S ratio
1,843.30x
EPS (TTM)
$-5.66
Dividend yield
—
52W range
$6 – $149
Volume
1.0M
Abivax SA American Depositary Shares (ABVX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73945.00 | $14000.00 | $42000.00 | $127000.00 | $10000.00 | $18000.00 | $2000.00 | $63000.00 | $37000.00 | $4.58M | $4.62M | $10.79M | $0.00 |
| Revenue growth (YoY) | — | -81.1% | +200.0% | +202.4% | -92.1% | +80.0% | -88.9% | +3050.0% | -41.3% | +12286.5% | +0.8% | +133.5% | -100.0% |
| Cost of revenue | $5.63M | $3.28M | $345000.00 | $14.64M | $14.51M | $68000.00 | $28.19M | $33.78M | $156000.00 | $110000.00 | $707000.00 | — | $1.03M |
| Gross profit | $-5.56M | $-3.27M | $-303000.00 | $-14.52M | $-6000.00 | $-50000.00 | $-28.19M | $-33.77M | $-119000.00 | $4.47M | $4.57M | $10.79M | $-1.03M |
| Gross margin | -7516.1% | -23321.4% | -721.4% | -11431.5% | -60.0% | -277.8% | -1409300.0% | -53601.6% | -321.6% | 97.6% | 99.0% | 100.0% | — |
| R&D | — | — | $15.27M | $15.46M | $10.85M | $15.89M | $29.01M | $34.53M | $47.78M | $48.73M | $103.18M | $146.53M | $170.75M |
| SG&A | $1.33M | $1.82M | $13.88M | $3.56M | $3.78M | $4.30M | $4.89M | $5.60M | $5.58M | $7.49M | $28.11M | $32.95M | $72.86M |
| Operating income | $-7.40M | $-5.05M | $-18.25M | $-18.24M | $-14.15M | $-19.11M | $-33.30M | $-38.01M | $-41.40M | $-64.84M | $-127.38M | $-172.98M | $-240.73M |
| Operating margin | -10003.6% | -36100.0% | -43464.3% | -14359.1% | -141500.0% | -106155.6% | -1664800.0% | -60330.2% | -111891.9% | -1414.7% | -2756.5% | -1602.9% | — |
| EBITDA | $-7.37M | $-4.97M | $-18.05M | $-18.16M | $-13.98M | $-19.23M | $-33.22M | $-38.00M | $-38.59M | $-53.31M | $-133.21M | $-171.88M | $-239.70M |
| EBITDA margin | -9972.8% | -35514.3% | -42988.1% | -14295.3% | -139800.0% | -106816.7% | -1661100.0% | -60315.9% | -104302.7% | -1163.3% | -2882.6% | -1592.7% | — |
| EBIT | $-7.39M | $-5.12M | $-18.19M | $-18.22M | $-14.07M | $-19.33M | $-33.30M | $-38.06M | $-38.75M | $-53.80M | $-133.91M | $-172.98M | $-240.73M |
| Interest expense | $168930.00 | $65000.00 | $168000.00 | $42000.00 | $31000.00 | $469000.00 | $1.59M | $2.06M | $3.56M | $6.94M | $13.83M | $4.18M | $27.39M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.89M | $-5.08M | $-15.95M | $-14.31M | $-11.22M | $-15.82M | $-30.63M | $-37.55M | $-42.45M | $-60.74M | $-147.74M | $-176.24M | $-322.84M |
| Net income growth (YoY) | — | +13.8% | -214.1% | +10.3% | +21.6% | -41.0% | -93.6% | -22.6% | -13.1% | -43.1% | -143.2% | -19.3% | -83.2% |
| Profit margin | -7970.2% | -36285.7% | -37985.7% | -11266.1% | -112230.0% | -87905.6% | -1531700.0% | -59604.8% | -114735.1% | -1325.3% | -3197.1% | -1633.1% | — |